HOME LOGIN DOCUMENT RESOURCES FAQs CONTACT INFO
Center for Biologic Counterterrorism
and Emerging Diseases CBC-ED
MedStar Health Group   Washington, DC     Cloud Updated Monday, September 6, 2010 17:22 EST
Craig Feied, MD, FACEP, FAAEM   Jon Handler, MD, FACEP   Michael Gillam, MD
Switch to framed viewerLogged in as: guest ()  
Glanders

The Type IV Pilin of Burkholderia mallei Is Highly Immunogenic but Fails To Protect against Lethal Aerosol Challenge in a Murine Model (pdf)
June 2007: American Society for Microbiology [5/18/2010]

Ready or Not — Preparedness for Bioterrorism
July 26 2001: NEJM [5/18/2010]

Glanders – a comprehensive review
September 2006: PubMed Abstract [5/18/2010]

Glanders in a Military Research Microbiologist(pdf)
May 26 2001: NEJM [5/18/2010]

Equine Glanders, Bahrain
May 10 2010: ProMED-mail [5/18/2010]

Critical Role of Type 1 Cytokines in Controlling Initial Infection with Burkholderia mallei(pdf)
2006: American Society for Microbiology [5/18/2010]

Burkholderia mallei cellular interactions in a respiratory cell model (pdf)
2009: Journal of Medical Microbiology [5/18/2010]

[This site developed and operated by Craig Feied MD, Jon Handler MD, and Mike Gillam MD]